Denmark· DK-28105903717
Berinert
A c1-inhibitor, plasma derived product containing c1-esterase inhibitor, human, registered in Denmark by CSL Behring GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
C1-inhibitor, plasma derived is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AC01 (c1-inhibitor, plasma derived), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
C1-inhibitor, plasma derived · ATC B06AC01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- C1-esterase inhibitor, human
- Manufacturer
- CSL Behring GmbH
- Country
- Denmark (DK)
- ATC code
- B06AC01
- ATC class
- C1-inhibitor, plasma derived
- Defined daily dose
- 1.4 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105903717
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
47 interactions on record for c1-inhibitor, plasma derived.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
C1-inhibitor, plasma derived · interactions on record
47 records
- 5 severe
- 42 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B06AC01
C1-inhibitor, plasma derived, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac80dbb4-e82f-4694-94e7-4b57811a18d3 GET /v1/drugs/ac80dbb4-e82f-4694-94e7-4b57811a18d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver og solvens til injektionsvæske, opløsning",
"source": "dkma",
"strength": "2000 IE",
"auth_role": "CMS",
"dk_drugid": "28105903717",
"substance": "C1-esterase inhibitor, human",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "43173"
}See everything about c1-inhibitor, plasma derived.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.